CMTM5-v1 induces apoptosis in cervical carcinoma cells

Luning Shao1, Xiaohuan Guo, Markus Plate

  • 1Peking University Center for Human Disease Genomics, Department of Immunology, Health Science Center, Peking University, 38 Xueyuan Road, Beijing 100191, China.

Insights

CKLF-like MARVEL transmembrane domain-containing member 5 (CMTM5) inhibits cervical carcinoma (CC) growth. Overexpression of CMTM5-v1 induces apoptosis in CC cells, primarily through a caspase-dependent pathway, verifying its tumor suppressor role.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • CKLF-like MARVEL transmembrane domain-containing member 5 (CMTM5) demonstrates tumor inhibition, frequently epigenetically silenced in cancers like cervical carcinoma (CC).
  • The primary RNA splicing variant, CMTM5-v1, is investigated for its functional role in CC cell lines.

Purpose of the Study:

  • To investigate the function of CMTM5-v1 in HeLa and SiHa cervical carcinoma cells.
  • To elucidate the mechanism by which CMTM5-v1 inhibits CC cell growth.

Main Methods:

  • Overexpression of CMTM5-v1 in HeLa and SiHa cells.
  • Assessment of apoptosis induction and its pathways.
  • Measurement of mitochondrial transmembrane potential, cytochrome c release, caspase-3 activation, and PARP cleavage.

Main Results:

  • CMTM5-v1 overexpression induced apoptosis in both HeLa and SiHa cells, with a more pronounced effect in SiHa cells.
  • In SiHa cells, CMTM5-v1 restoration led to mitochondrial dysfunction, cytochrome c release, and caspase-3 activation.
  • Caspase inhibition significantly reduced CMTM5-v1-induced apoptosis, indicating a caspase-dependent mechanism.

Conclusions:

  • CMTM5-v1 inhibits the growth of cervical carcinoma cell lines.
  • CMTM5-v1 induces apoptosis in CC cells via a caspase-dependent pathway involving mitochondrial disruption.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...